AN OVERVIEW OF IDIOPATHIC PULMONARY FIBROSIS

Idiopathic pulmonary fibrosis (IPF) is a severe lung disease. During breathing, oxygen moves through the air sacs in the lungs and into the bloodstream, and then into the organs. In the case of IPF, the disease causes scar tissue to grow within the lungs making it difficult to breathe. The condition of IPF worsens with time. The lung damage that is caused due to Idiopathic pulmonary fibrosis is progressive and irreversible.

What are the symptoms of idiopathic pulmonary fibrosis? Dry cough, a cough that doesn’t go away, appetite loss, breathlessness specially while doing activities like walking, chest pain, tightness in the chest, swelling in the leg, fatigue, unexplained weight loss, clubbing of the fingers or toes, pain in the joints and muscles are some common symptoms of idiopathic pulmonary fibrosis. 

What causes Idiopathic pulmonary fibrosis? The exact cause behind IPF is not known. However, there are certain risk factors that are associated with the risk of developing idiopathic pulmonary fibrosis. These risk factors are, older age (above 50), exposure to metal dust or wood dust at home or workplace, genetics, having acid reflux condition, and smoking. Diagnosis of IPF includes various tests like chest X-ray, biopsy, Pulse oximetry, arterial blood gas tests, High-resolution chest CT, and Spirometry. 

Eating healthy, exercising, not smoking, and getting flu shots on time to protect against diseases like pneumonia that can cause damage to the lungs are some things that can be done by the patient to feel better. Idiopathic pulmonary fibrosis increases the risk of developing pulmonary hypertension, stroke, heart attacks, blood clots within the lungs, lung cancer and other lung infections in the patient.

There is no cure available for idiopathic pulmonary fibrosis. The treatment usually involves relieving the symptoms. Pulmonary rehabilitation, Oxygen therapy and use of certain medications are the available treatment options for IPF. In case of severe, IPF, a lung transplantation surgery might be performed. 

Nintena 150mg Capsule is a medication used to treat idiopathic pulmonary fibrosis. It contains the active ingredient Nintedanib, and it works by causing inhibition of multiple receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases (nRTKs). This medication, interferes with the production and migration of fibroblasts, thereby affecting it signaling. As a result of this, the further scarring and stiffening of the lungs is reduced. If you have IPF, then your doctor might prescribe you Nintena 150mg Capsule.


Comments

Popular posts from this blog

Importance of antineoplastic drug in breast cancer treatment

Fungal ergosterol synthesis inhibitor uses and applications

The Startling Increase in Lung Cancer Cases: A Result of Smog Pollution